Crossmark

Preclinical Evaluation of Acylhydrazone SB-AF-1002 as a Novel Broad-Spectrum Antifungal Agent

Crossref DOI link: https://doi.org/10.1128/AAC.00946-20

Published Print: 2020-08-20

Update policy: https://doi.org/10.1128/asmj-crossmark-policy-page

Authors

Lazzarini, Cristina

Haranahalli, Krupanandan

McCarthy, J. Brian

Mallamo, John

Ojima, Iwao

Del Poeta, Maurizio https://orcid.org/0000-0001-8418-3120
Funding

Funding for this research was provided by:

HHS | NIH | National Institute of Allergy and Infectious Diseases (AI116420)

HHS | NIH | National Institute of Allergy and Infectious Diseases (AI125770)
License Information

Text and Data Mining valid from 2020-08-20
More Information

Publication History

Received: 2020-05-09

Accepted: 2020-06-22

Published: 2020-08-20